M.G. Glaser
- Genetics top 1%
- Glioma Diagnosis and Treatment 12
- Neurology top 5%
- CNS Lymphoma Diagnosis and Treatment 6
- Neuroblastoma Research and Treatments 4
-
- Brain Metastases and Treatment 5
- Medical Imaging and Pathology Studies 3
- Oncology top 10%
-
- Head and Neck Cancer Studies 4
-
- Head and Neck Surgical Oncology 3
-
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- E.S. NewlandsIain ColquhounStephen R. WedgeC. BrockMark BowerHelen EvansPaul D. LewisR D Illingworth
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
M.G. Glaser
34 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 89
- Genetics 775
- Neurology 379
- Pathology and Forensic Medicine 296
- Pulmonary and Respiratory Medicine 444
- Oncology 275
Countries citing papers authored by M.G. Glaser
This map shows the geographic impact of M.G. Glaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G. Glaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G. Glaser more than expected).
Fields of papers citing papers by M.G. Glaser
This network shows the impact of papers produced by M.G. Glaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G. Glaser. The network helps show where M.G. Glaser may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M.G. Glaser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 30 | |
| 2 | 2000 | 129 | |
| 3 | 1999 | 49 | |
| 4 | 1999 | 54 | |
| 5 | 1999 | 4 | |
| 6 | Phase I trial of temozolomide using an extended continuous oral schedule. | 1998 | 228 |
| 7 | Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in primary CNS lymphoma (PCL)- BR06. | 1998 | 1 |
| 8 | 1997 | 112 | |
| 9 | 1996 | 122 | |
| 10 | 1993 | 4 | |
| 11 | 1993 | 231 | |
| 12 | 1993 | 4 | |
| 13 | 1993 | 11 | |
| 14 | 1992 | 3 | |
| 15 | 1992 | 21 | |
| 16 | 1990 | 1 | |
| 17 | 1990 | 11 | |
| 18 | 1989 | 9 | |
| 19 | 1983 | 25 | |
| 20 | 1981 | 12 |
About M.G. Glaser
M.G. Glaser is a scholar working on Genetics, Otorhinolaryngology and Neurology, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (12 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (5 papers), Neuroblastoma Research and Treatments (4 papers), Head and Neck Cancer Studies (4 papers), Medical Imaging and Pathology Studies (3 papers), Head and Neck Surgical Oncology (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Genetics (775 citations), Neurology (379 citations) and Pathology and Forensic Medicine (296 citations). M.G. Glaser has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include E.S. Newlands, Iain Colquhoun, Stephen R. Wedge, C. Brock, Mark Bower, Helen Evans, Paul D. Lewis, R D Illingworth, S.M. O'Reilly and Peter G. Richards. Their work appears in journals such as Clinical Oncology, Clinical Radiology, Cancer, European Journal of Cancer and Journal of the Royal Society of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.